Abstract:Background Human defensin peptides with broad-spectrum antimicrobial activity have been implicated in the human defence response towards microbial invasion. Two families of defensins designated alpha- and beta-defensins, respectively, have been identified. Little is known about the expression of both defensin families in human peripheral blood. The purpose of this study was to examine the expression of alpha- and beta-defensin genes in human peripheral blood. Material and methods Fifty-one healthy blood donors were screened for defensin expression. Blood from defensin responders was stimulated by lipopolysaccharide or heat-inactivated Pseudomonas aeruginosa ex vivo. Levels of mRNA were assessed by semiquantitative RT-PCR. Southern blot analysis and sequencing were used to confirm the identity of defensin gene transcripts. Western blotting analysis was used to detect the expression of defensin peptides. Results beta-defensin was undetected in human peripheral blood without stimulation. Following stimulation by lipopolysaccharide or heat-inactivated bacterial cells, the majority (88.2%) of healthy individuals had a detectable expression for beta-defensin-1 gene and 39.2% for beta-defensin-2 gene, compared with none for beta-defensin-3. beta-defensin-1 and -2 mRNAs in the stimulated human peripheral blood of responders became detectable at 3 h and showed a maximum at 6 h following induction by 100 ng mL(-1) of lipopolysaccharide or bacterial cells. In contrast, human alpha-defensins 1-3 mRNA are constitutively expressed in peripheral leukocytes but not up-regulated by lipopolysaccharide or bacterial cells. Conclusions In human peripheral blood, beta-defensin-1 and -2 genes were transiently transcribed and translated following the induction of lipopolysaccharide or heat-inactivated bacterial cells, whereas a-defensins 1-3 genes were constitutively transcribed, and beta-defensin-3 gene was not expressed. The inducible expression of beta-defensin-1 and -2 genes showed interindividual variability.

Human Β-Defensin 2 is a Novel Opener of Ca 2+ -Activated Potassium Channels and Induces Vasodilation and Hypotension in Monkeys

Human beta-defensin 1, a new animal toxin-like blocker of potassium channel

Endogenous Animal Toxin-Like Human Β-Defensin 2 Inhibits Own K+ Channels Through Interaction with Channel Extracellular Pore Region

Pharmacological Characterization of Human Beta-Defensins 3 and 4 on Potassium Channels: Evidence of Diversity in Beta-Defensin-potassium Channel Interactions.

Human Α‐defensins Are Immune‐related Kv1.3 Channel Inhibitors: New Support for Their Roles in Adaptive Immunity

Kv Channel S1-S2 Linker Working As a Binding Site of Human Β-Defensin 2 for Channel Activation Modulation*

Mouse β-Defensin 3, A Defensin Inhibitor of Both Its Endogenous and Exogenous Potassium Channels.

Mouse β-Defensin 3, A Defensin Inhibitor of Both Its Endogenous and Exogenous Potassium Channels

Advancement of Human Βdefensin-2 and Its Role in Pulmonary Diseases

Structural Analysis of Human β-Defensin-1 and Its Significance in Urinary Tract Infection

Differential Expression of Α‐ and Β‐defensins in Human Peripheral Blood

[Advances in the Research of Human Defensins].

Differential expression of alpha- and beta-defensins in human peripheral blood.

Human Beta-Defensin 2 and 3 Inhibit HIV-1 Replication in Macrophages

Human β-Defensin 2 Mediated Immune Modulation as Treatment for Experimental Colitis

Human β-defensin 2: a connection between infections and allergic skin diseases

Human β-defensins and their synthetic analogs: Natural defenders and prospective new drugs of oral health

Sphingosine Kinase-1 is Required for Toll Mediated Beta-Defensin 2 Induction in Human Oral Keratinocytes.

Defensins, a novel type of animal toxin-like potassium channel inhibitor

Upregulation of human beta-defensin 2 peptide expression in oral lichen planus, leukoplakia and candidiasis. an immunohistochemical study

Antimicrobial Characterization of Human -Defensin 3 Derivatives